Watch Ticker

Innate Pharma S.A. ADS

Go to Innate Pharma S.A. ADS Website

$2.18

0.03 (1.40%)

Live

Previous Close

$2.11

Day Range

$2.09 - $2.225

Previous Day Range

$2.14 - $2.22

Market Cap

$198.2 million USD

Day Vol.

3597

Previous Day Vol.

10387

Currency

USD

Primary Exchange

Nasdaq

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Enga...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight

The non-Hodgkin's lymphoma market is expected to grow significantly between 2025-2034, driven by increasing incidence, advancements in targeted therapies, emerging treatments, and improved early detection efforts.

Related tickers: SNGX, IPHA, NRIX, MRK.

Read Full Article

Delveinsight - Cutaneous T-cell Lymphoma Market Anticipates Impressive Growth Trajectory at a CAGR of 7.1% During the Study Period (2020–2034) | DelveInsight

The cutaneous T-cell lymphoma market is expected to grow at a 7.1% CAGR from 2020-2034, driven by research advancements, increasing prevalence, and emerging therapies targeting this rare lymphoma.

Related tickers: SNGX, IPHA.

Read Full Article

Trending Tickers

Please sign in to view